CAS RN: 20559-55-1
Oxibendazole
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 2 grade groups
Grade
≥98% (2)
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250321
250mg
In stock
Inquiry
Batchno.20260505
50mg
In stock
Inquiry
Batch No. Package Availability Warehouse Inquiry
Batchno.20250617
50mg / 250mg / 1g / 5g / 25g / 100g
Confirm by inquiry
Shanghai, Hebei Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 20559-55-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥98%
0
Out of Stock
Shanghai
Inquiry
20559-55-1 / methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate
Standard CAS: 20559-55-1
Multi CAS: No
Basic Information
copy
CAS
20559-55-1 copy
Multi CAS
No copy
Molecular Formula
C12H15N3O3 copy
Molecular Weight
249.270000 copy
Exact Mass
249.111341 copy
SMILES
CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC copy
InChI
InChI=1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) copy
InChIKey
RAOCRURYZCVHMG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.33 copy
Rotatable bonds
4 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
67.91 copy
TPSA
76.24 copy
LogP / Solubility
WLOGP
2.53 copy
MLOGP
2.23 copy
XLogP3
2.4 copy
Consensus LogP
2.39 copy
Log S (ESOL)
-3.09 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.43 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.86 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.44 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy